Prostate cancer: ESMO consensus conference guidelines 2012

A. Horwich, J. Hugosson, T. de reijke, T. Wiegel, K. Fizazi, V. Kataja, Chris Parker, Joaquim Bellmunt, Dominik Berthold, Anna Bill-axelson, Sigrid Carlsson, Gedske Daugaard, Gert De meerleer, Theo De reijke, David Dearnaley, Valérie Fonteyne, Silke Gillessen, Daniel Heinrich, Jonas Hugosson, Vesa KatajaMaciej Kwiatkowski, Sten Nilsson, Anwar Padhani, Christos Papandreou, Monique Roobol, Avishay Sella, Riccardo Valdagni, Theo Van der kwast, Paul Verhagen, Thomas Wiegel

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Abstract

The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

Original languageEnglish
Pages (from-to)1141-1162
Number of pages22
JournalAnnals of Oncology
Volume24
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Keywords

  • Consensus
  • ESMO
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Prostate cancer: ESMO consensus conference guidelines 2012'. Together they form a unique fingerprint.

Cite this